Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I expect it to, but that may be "hope" talking.
I bought while stoned...fat fingered the number of shares, so ended up with a pile. Averaged at 13.30/shr after split and am looking for 20.
Good luck.
do you think this may go up some with the merger?
The closing of the merger is anticipated to take place on or around October 5, 2020. Following closing of the merger, the combined company will be renamed Chinook Therapeutics and trade under the trading symbol “KDNY.”
Aduro Biotech Stockholders Approve Merger Agreement with Chinook Therapeutics....
https://www.globenewswire.com/news-release/2020/10/01/2102576/0/en/Aduro-Biotech-Stockholders-Approve-Merger-Agreement-with-Chinook-Therapeutics.html
That was fun.... wake up to a 400%+ gainer and find out a R/S was the cause. I forgot that was coming. I guess we get our new ticker Monday.
It was fun to watch today... up even more after hours.
Seems investors don't like the upcoming merger....
"– Combined Company Will Operate as Chinook Therapeutics and Advance Pipeline of Clinical-Stage Programs in Kidney Diseases, Led by Atrasentan and BION-1301 in IgA Nephropathy
– Combined Company Will be Well-Funded With Cash Position of ~$200 Million Expected at Closing, Including $25 Million in Additional Investment Committed by Chinook’s Existing Investors"
https://www.globenewswire.com/news-release/2020/06/02/2042120/0/en/Aduro-Biotech-and-Chinook-Therapeutics-Announce-Definitive-Merger-Agreement.html
my thoughts: going higher
Any thoughts on the 20%+ bounce on this today, or am I the only nut playing this?
CBOE BZX REAL-TIME LAST SALE
2.79 USD
TODAY'S CHANGE
+0.51increase +22.37%increase
VOLUME
982,159
PRICE QUOTE AS OF
13:41 ET
* * $ADRO Video Chart 02-14-2020 * *
Link to Video - click here to watch the technical chart video
* * $ADRO Video Chart 02-13-2020 * *
Link to Video - click here to watch the technical chart video
* * $ADRO Video Chart 02-07-2020 * *
Link to Video - click here to watch the technical chart video
* * $ADRO Video Chart 02-05-2020 * *
Link to Video - click here to watch the technical chart video
* * $ADRO Video Chart 02-04-2020 * *
Link to Video - click here to watch the technical chart video
* * $ADRO Video Chart 02-03-2020 * *
Link to Video - click here to watch the technical chart video
Near the HOD. How about 2 bones tomorrow??
* * $ADRO Video Chart 01-31-2020 * *
Link to Video - click here to watch the technical chart video
$ADRO: Wow.... $7price target
SVB Leerink just raised it from $3 target
Buy all you can here at $1.63
And don't hold back.
This could really go.
I'm in for sure !
GO $ADRO
* * $ADRO Video Chart 11-08-19 * *
Link to Video - click here to watch the technical chart video
They stole ADXS's crumbs and now are reeling from the disaster!
Rated strong buy- could see some volume soon...
https://finance.yahoo.com/news/aduro-biotech-adro-upgraded-strong-140902253.html
ADRO ready for a 50%+ move
Big partners
Elly lilly
Novartis
Merck
Milestone payments
3.30 cash per share
2.00 book value.
Chart set up for a move
A new preclinical paper https://www.cell.com/cell-reports/fulltext/S2211-1247(18)31810-2
* * $ADRO Video Chart 12-19-18 * *
Link to Video - click here to watch the technical chart video
LOOKS LIKE I WILL BE TWERKING... ALL THE WAY TO THE BANK -->>
N thats how you take care of business!!! Yeall have a nice day!!!
FROM HERE ON OUT $HIT BE FADING AWAY!!! $$$$$$$ -->>
WHO THE F... IS GONNA STEPUP??? NOONE!!! IM THE BEST WATCH ME FLEX THIS SHORT GAME EVERY DAY PLAYAZ!!!
I AM UNLIMITED!!! AINT NOBODY BETTA DEN ME!!! BUT AT LEAST YOU CAN GET A TASTE -->>
In one interview Dr. Jaffee said a pilot trial investigating a neoantigen vaccine (synthetic long peptides plus STING adjuvant), anti-OX40 and anti-PD-1 will take place in patients with MSS CRC and mPADC. Here is the preclinical study https://insight.jci.org/articles/view/122857
Dr. Luke presented data on $BMY's STING agonist [1] as well as one by $SBPH [2] and Actym Therapeutics [3].
1 https://pbs.twimg.com/media/DtUqr7-WsAAkxFv.jpg
2 https://pbs.twimg.com/media/DtUqr7_WkAEWxuN.jpg
3 https://pbs.twimg.com/media/DtUqr8DWwAAlai1.jpg
Most had failed a number of lines of therapy and over 46% had treatment with a checkpoint inhibitor. So you shouldn't expect to see much evidence for efficacy in a PhIa trial. The main purpose of these is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of a drug.
what about the 35 out of 41 (85%) pts that stopped treatment STING SINGLE AGENT
SITC abstract https://pbs.twimg.com/media/DrUnGSyXcAA6Wvh.jpg
The company will host and webcast an investor event on Friday, November 9, 2018 at 6:30 p.m. Eastern Time in Washington, D.C.
It should activate the pathway in multiple cells in the TME (including macrophages and ECs to name of few). The innate response is via neutrophils after TNFa has caused hemorrhagic necrosis. Adaptive response is dependent on STING and IFNB activation in DCs. Abscopal effects through polyfunctional antigen specific T-cells.
Does ADRO's STING stimulate the same immune cells as AFMD's NK, Natural Killer cells, or does ADRO stimulate T-cells(which kill) and B-cells(which produce antibodies)?
Would really appreciate your answer.
Thanks
Personalised LADD won't be moving forward after the current PhI is completed. The company now looks to licence it.
$JNJ has terminated the exclusive global license agreement to develop ADU-214, ADU-741 and GVAX Prostate for all indications. From the wording I don't hold out much hope for pLADD.
https://www.sec.gov/Archives/edgar/data/1435049/000119312518289503/d619516d8k.htm
I will no longer buy Advaxis common stock and I will not recommend it to anybody I like. I will however continue to hold my shares and vote NO to everything management wants until they sell the company.
Anybody who does their job with such ineptitude as the BOD and management of this company doesn’t deserve to have a job.
Followers
|
10
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
108
|
Created
|
04/14/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |